2024-2025 / Master

Pharmacy, professional focus in community pharmacy management and professional issues

120 crédits

Cycle view

  • Bloc
  • Organization
  • Theory
  • Practical
  • Others
  • Credits

Focus courses

B2
30Cr
CodeDetailsBlocOrganizationTheoryPracticalOthersCredits
GEST7052-1Medical administration and managementB2Q1   5
Companies and corporate law   9-- 
Administrative management - [3h Seminar]   9-[+] 
Accountancy, reporting and income statements   6-- 
Freelance or employee   6-- 
Corporate income tax and private persons tax   6-- 
Storage management   6-- 
Price policy - [3h Seminar]   4-[+] 
QUAL0726-1Leadership and managing human resourcesB2Q1   5
Human ressources   20-- 
Quality management in the dispensary   10-- 
Risk management   10-- 
Well-being at work
  10-- 
PHAR0720-1Professional developmentB2Q1   5
Sectorial analysis   10-- 
New services - [24h Visit]   126[+] 
Creative methods and approaches - [3h Seminar]   8-[+] 
MSTG0765-1Placement - [210h internship] B2Q1--[+]7
GEST7053-1Personal research work - [20h Supervision of internship, 40h Personal research] B2Q1--[+]8

Cours du tronc commun

B1
60Cr
B2
30Cr
CodeDetailsBlocOrganizationTheoryPracticalOthersCredits
PHAR0344-3Medicines analysis B1Q14528-7
PHAR0343-3Pharmaceutical technologies and biopharmacy (part I) B1Q12060-4
PHAC0341-2Special pharmacology (Part I) B1Q125--3
TOXI0341-2Toxiocological chemistry, Part IB1Q1   4
Toxiocological chemistry   25-- 
Toxicological chemistry, supplement for pharmacy - [12h Seminar]   --[+] 
BIOC0340-1Clinical Chemistry (Part I) - [12h Seminar] B1Q122-[+]4
MBIO0002-1Pharmaceutical Microbiology B1Q116--2
PHAR2018-1Officinal pharmaceutical good practices - [6h Seminar] B1Q110-[+]2
ECON0340-1Pharmacoeconomy B1Q110--1
PHAR0003-1
Pharmaceutical tehcnologies and biopharmacy (part II) - [5h Seminar]
Corequisite
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
B1Q225-[+]4
PHAR0347-3Practical work - Pharmaceutical technologies and Biopharmacy
Corequisite
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
B1Q2-32-2
PHAC0342-2Special pharmacology (Part II)
Corequisite
PHAC0341-2
Pharmacologie spéciale (Partim I)
B1Q220--2
TOXI0342-2Clinical Toxicology and adverse drug events monitoring (Part II) - [12h Seminar]
Corequisite
TOXI0341-2
Chimie toxicologique, Partim I
B1Q225-[+]4
BIOC0341-1Clinical chemistry (2nd part) - [12h Seminar]
Corequisite
BIOC0340-1
Chimie clinique (Partim I)
B1Q223-[+]4
PHAR0004-1Pharamcotherapy and pharmaceutical cares - [10h Seminar] B1Q230-[+]5
SANT0005-1Therapeutic approach - [30h Séminaire Interdisciplinaire] B1Q2--[+]3
LEGI0340-2Legislation and pharmaceutical ethics B1Q230--4
PHAR2219-1Integrated work 2 - [30h Learning based on problem-solv]
Corequisite
PHAC0341-2
Pharmacologie spéciale (Partim I)
PHAC0342-2
Pharmacologie spéciale (Partim II)
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0344-3
Analyse des médicaments
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
B1Q2--[+]3
PHAR2020-1Integrated practical activitiesB1Q2   2
Integrated practical work   -40- 
Industrial visits - [25h Visit]
Corequisite
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0344-3
Analyse des médicaments
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
  --[+] 
APPR0160-2Professional development Seminar - [30h Learning based on problem-solv]
Corequisite
MTFE0351-3
Stage officinal et travail de fin d'études
B2Q2--[+]5

Compulsory Training

PHAR0721-1Incorporation of pharmaceutical knowledge
Corequisite
MTFE0351-3
Stage officinal et travail de fin d'études
B2Q2-50-5
MTFE0351-3Officinal Internship and Thesis B2Q2   20
Record of learning and participation to clinical research project - [100h Personal research]   --[+] 
Officinal internship and Thesis - [6mois internship]
Prerequisite
TOXI0342-2
Chimie toxicologique y compris pharmacovigilance (Partim II)
PHAR2018-1
Bonnes pratiques pharmaceutiques officinales
PHAR0347-3
Travaux pratiques - Technologie pharmaceutique et biopharmacie
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
PHAC0342-2
Pharmacologie spéciale (Partim II)
PHAC0341-2
Pharmacologie spéciale (Partim I)
LEGI0340-2
Législation et déontologie pharmaceutiques
BIOC0341-1
Chimie clinique (Partim II)
Corequisite
PHAR0721-1
Intégration des connaissances pharmaceutiques
  --[+] 
Notice : Les étudiants doivent accomplir un stage officinal d'une durée légale de six mois (26 semaines), associé à la rédaction d'un dossier d'apprentissage (TFE).
Ce stage comprend un stage d'initiation obligatoire de 2 semaines, durant l'été, à l'issue du cycle de bachelier. Pour les étudiants ayant acquis au minimum 45 crédits du bloc 1 du master, le stage officinal peut se poursuivre pendant les vacances d'été précédant l'entrée au bloc 2 du master (maximum 8 semaines). Le solde de semaines (minimum 16 semaines) est presté dans le cadre du bloc 2 du master (2e quadrimestre).